BRAF V600E mutation is a useful marker for differentiating Rathke's cleft cyst with squamous metaplasia from papillary craniopharyngioma

J Neurooncol. 2015 May;123(1):189-91. doi: 10.1007/s11060-015-1757-6. Epub 2015 Mar 28.

Authors

Jang-Hee Kim¹, Werner Paulus, Stephanie Heim

Affiliation

¹ Department of Pathology, Ajou University School of Medicine, 164, World Cup-ro, Yeongtong-gu, Suwon, 443-380, Republic of Korea, [email protected].

PMID: 25820214
DOI: 10.1007/s11060-015-1757-6

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Biomarkers, Tumor / genetics*
Carcinoma, Papillary / diagnosis*
Carcinoma, Papillary / genetics
Central Nervous System Cysts / diagnosis*
Central Nervous System Cysts / genetics
Craniopharyngioma / diagnosis*
Craniopharyngioma / genetics
Diagnosis, Differential
Female
Humans
Male
Metaplasia / diagnosis*
Metaplasia / genetics
Middle Aged
Mutation / genetics
Neoplasm Staging
Pituitary Neoplasms / diagnosis*
Pituitary Neoplasms / genetics
Prognosis
Proto-Oncogene Proteins B-raf / genetics*
Young Adult

Substances

Biomarkers, Tumor
BRAF protein, human
Proto-Oncogene Proteins B-raf